| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |